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(57) ABSTRACT 
Provided herein are devices and methods for the micro-iso-
lation of biological cellular material. A micro-isolation appa-
ratus described can comprise a photomask that protects 
regions of interest against DNA-destroying illumination. The 
micro-isolation apparatus can further comprise photosensi-
tive material defining access wells following illumination and 
subsequent developing of the photosensitive material. The 
micro-isolation apparatus can further comprise a chambered 
microfluidic device comprising channels providing access to 
wells defined in photosensitive material. The micro-isolation 
apparatus can comprise a chambered microfluidic device 
without access wells defined in photosensitive material where 
valves control the flow of gases or liquids through the chan-
nels of the microfluidic device. Also included are methods for 
selectively isolating cellular material using the apparatuses 
described herein, as are methods for biochemical analysis of 
individual regions of interest of cellular material using the 
devices described herein. Further included are methods of 
making masking arrays useful for the methods described 
herein. 
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METHODS AND DEVICES FOR 
MICRO-ISOLATION, EXTRACTION, AND/OR 
ANALYSIS OF MICROSCALE COMPONENTS 
CROSS REFERENCE TO RELATED 
APPLICATIONS 
This present application claims priority to U.S. Provisional 
Application No. 61/297,207, filed on Jan. 21, 2010, and U.S. 
Provisional Application No. 61/309,292, filed on Mar. 1, 
2010, each of which is incorporated herein by reference in its 
entirety. 
STATEMENT OF GOVERNMENT GRANT 
The invention described herein was made in the perfor-
mance of work under a NASA contract, and is subject to the 
provisions of Public Law 96-517 (35 USC 202) in which the 
Contractor has elected to retain title. 
FIELD 
The present disclosure relates to micro-isolation ofmicros-
cale components such as tissue and/or cell samples. More 
specifically, it relates to methods and devices for such micro-
isolation. 
BACKGROUND 
The isolation of certain microscale components is an 
important factor in several applications where the ability to 
differentially analyze properties exhibitedby varying types of 
components (e.g. cell types) is desired. 
For example, the ability to recognize properties typical of a 
component included in a matrix with other similar compo-
nents, can be of importance in various fields, including in 
particular biological fields. In particular, the ability to identify 
properties which cause a cell to behave in a certain way is 
expected to promote an understanding of how cells behave 
both normally and abnormally. For example, the ability to 
selectively analyze cancerous cells is expected to provide 
insight into the particular biochemical activities ofthose cells 
relative to normal cells. 
However, separating different cell types and in particular 
cancerous cells from non-cancerous cells can be a difficult 
endeavor. 
SUMMARY 
Provided herein are apparatuses and methods for the 
micro-isolation of micro-scale components such as cellular 
material, whichin several embodiments provideforthe selec-
tive biochemical analysis of desired components. 
According to a first aspect, a micro-isolation apparatus is 
provided. The micro-isolation apparatus comprises a support, 
a cellular material mounted upon the support, a photomask 
comprising a transparent region and a non-transparent block-
ing region, the non-transparent blocking region covering at 
least a portion of the transparent region, wherein the photo-
mask is placed over the cellular material such that the block-
ing region is positioned to correspond to a region of interest of 
the cellular material to minimize damage to the cellular mate-
rial in the region of interest by illumination. 
According to a second aspect, a micro-isolation apparatus 
is provided. The micro-isolation apparatus comprises a sup-
port, a cellular material mounted upon the support, and a 
photosensitive material deposited on the cellular material 
wherein the photosensitive material comprises an access well 
positioned to correspond to a region of interest of the cellular 
material. Some embodiments can further include a cham-
bered microfluidic device comprising at least one channel that 
5 provides access to the access well and is positioned adjacent 
to a photosensitive material located above the cellular mate-
rial. 
According to a third aspect, a micro-isolation apparatus is 
provided. The micro-isolation apparatus comprises a first 
io photosensitive material deposited on cellular material 
adapted to be contained in the apparatus, wherein the first 
photosensitive material comprises a first access well posi-
tioned to correspond to a region of interest of the cellular 
material, a first chambered microfluidic device comprising at 
15 least one channel that provides access to the first access well 
and is positioned adjacent to the first photosensitive material, 
a second photosensitive material adapted to be deposited on 
the cellular material opposite to the first photosensitive mate-
rial wherein the second photosensitive material comprises a 
20 second access well positioned to correspond to an opposing 
side of the region of interest of the cellular material, and a 
second chambered microfluidic device comprising at least 
one channel that provides access to the second access well 
and is positioned adjacent to the second photosensitive mate- 
25 rial. In some embodiments, the first chambered microfluidic 
device provides an input to the region of interest of the tissue 
and/or cells and the channel or channels of the second cham-
bered microfluidic device provide an output from the region 
of interest of the tissue and/or cells. 
30 	 According to a fourth aspect, a maskless micro-isolation 
apparatus is provided. The apparatus comprises cellular 
material, a first chambered microfluidic device comprising 
multiple channels, wherein each channel provides access to 
respective regions of interest of the cellular material, and a 
35 second chambered microfluidic device comprising multiple 
channels positioned to correspond to the regions of interest of 
the cellular material that are opposite to the regions of interest 
corresponding to the first chambered microfluidic device. 
According to a fifth aspect, a method for selectively isolat- 
40 ing cellular material is provided. The method comprises posi-
tioning cellular material on a support, placing a photomask 
comprising a blocking region covering at least part of a block-
ing support over the cellular material such that the blocking 
region corresponds to a region of interest of the cellular 
45 material, and exposing the cellular material to photons 
wherein the photons penetrate the blocking support without 
penetrating the blocking region so that the cellular material in 
the region of interest is preserved and the cellular material 
that is not in the region of interest is damaged. 
50 	 According to a sixth aspect, a method for selectively iso- 
lating cellular material is provided. The method comprises 
positioning cellular material on a support, depositing a pho-
tosensitive material on the cellular material, applying a pho-
tomask comprising a blocking region onto the photosensitive 
55 material, exposing the photosensitive material through a light 
accessible region of the photomask to photons in order to 
generate a lithographic pattern on the photosensitive material, 
removing the photomask, and applying a developer to the 
photosensitive material in order to define an access well cor- 
6o responding to a region of interest of the cellular material. 
According to a seventh aspect, a method for selectively 
isolating cellular material is provided. The method comprises 
positioning cellular material on a support, depositing a pho-
tosensitive material on the cellular material, exposing the 
65 photosensitive material to photons in order to generate a 
lithographic pattern on the photosensitive material, removing 
the photomask, and applying a developer to the photosensi- 
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tive material in order to define an access well corresponding 
to a region of interest of the cellular material. 
According to an eighth aspect, a method for selectively 
isolating cellular material is provided. The method comprises 
positioning cellular material on a support, and exposing an 5 
unwanted region of the cellular material to photons to selec-
tively damage DNA in the unwanted region of the cellular 
material while not exposing a wanted region of the cellular 
material to minimize damage to the DNA in the wanted 
region. 10 
According to a ninth aspect, a method to analyze a biologi-
cal sample is provided. The method comprises forming 
microfluidic access wells in a substrate, filling the microflu-
idic access wells with a reaction mixture comprising diges-
tion agents and components necessary for a desired reaction, 15 
evaporating the mixture to uniformly decrease the reaction 
mixture level, aligning a support comprising cellular material 
facing downward on top of the microfluidic access wells such 
that the cellular material is exposed to the reaction mixture, 
vertically turning over the access wells comprising the sup- 20 
port and cellular material, allowing the reaction mixture to 
flow by gravity to cover the cellular material, allowing the 
digestion agents to break down the cellular material, releasing 
contents from the cellular material into the microfluidic 
access wells, and performing the reaction simultaneously but 25 
separately in each of the microfluidic access wells. 
According to a tenth aspect, a method to analyze a biologi-
cal sample is provided. The method comprises positioning 
cellular material on a first support, applying a maskless 
microisolation apparatus comprising one or more randomly 30 
placed first access wells, filling the one or more first access 
wells with a reaction mixture comprising digestion agents 
and components necessary for a desired reaction, allowing 
the digestion agents to digest the cellular material thereby 
releasing cellular contents into the reaction mixture, inacti- 35 
vating the digestion agents, filling one or more second access 
wells in a second support corresponding to the one or more 
first access wells with an analytical reaction mixture, evapo-
rating a fraction of the mixture to uniformly decrease the 
reaction mixture level, aligning the first support on top of the 40 
second support such that the one or more first access wells 
face the one or more second access wells, securing the first 
and second support, inverting the secured support to allow the 
analytical reaction mixture to contact the cellular contents, 
and performing a reaction simultaneously but separately in 45 
each well of the array. 
According to an eleventh aspect, a method to isolate a 
region of interest of cellular material is provided. The method 
comprises positioning cellular material on a support, depos-
iting a negative photosensitive material on the cellular mate- 50 
rial, capturing an image of the cellular material through the 
negative photosensitive material as reflected on a processing 
mirror or mirror array, positioning the processing mirror or 
programming the mirror array such that photons are directed 
to the negative photosensitive material over an unwanted 55 
region of the cellular material to laminate the negative pho-
tosensitive material over the unwanted region of the cellular 
material while leaving a region of interest of the cellular 
material non-laminated, and removing the negative photosen-
sitive material that has not been laminated so that the region of 60 
interest of the cellular material is exposed while the unwanted 
region of the cellular material is sealed. 
According to a twelfth aspect, a method to isolate a region 
of interest of cellular material is provided. The method com- 
prises positioning cellular material on a support, capturing an 65 
image of the cellular material as reflected on a processing 
mirror or mirror array, positioning the processing mirror, or 
programming a mirror array, such that photons are directed to 
an unwanted region of the cellular material to damage DNA in 
the unwanted region of the cellular material while leaving 
DNA in a cellular region of interest intact. 
According to a thirteenth aspect, a method for making a 
micro-isolation apparatus is provided. The method comprises 
positioning cellular material on a support, identifying an 
unwanted region of interest of the cellular material, convert-
ing a selection into a digital image, transferring the digital 
image to a plate comprising a layer of photosensitive material 
over a metal, using a laser to trace a digital mask on the 
photosensitive material, developing the photosensitive mate-
rial to remove exposed photosensitive material, chemically 
etching the metal in the area where the photosensitive mate-
rial has been removed, and removing remaining photosensi-
tive material to produce a plate comprising a layer of metal in 
a pattern where the metal is absent corresponding to the 
unwanted region of interest of the cellular material and the 
metal remaining corresponds to a region of interest of the 
cellular material. 
According to a fourteenth aspect, a method of making an 
active masking array is provided. The method comprising 
positioning cellular material on a support, identifying a 
region of interest of the cellular material, polarizing an illu-
mination light along a first axis, directing the illumination 
light through (e.g. liquid crystal) polarizer elements that are 
aligned or programmed in such a way that the illumination 
light is absorbed in the polarizer elements over regions of 
interest of the cellular material while allowing the illumina-
tion light to damage DNA or cellular material in an unwanted 
region of the cellular material to preserve the DNA or cellular 
material in the region of interest of the cellular material. 
According to a fifteenth aspect, a method of making an 
active array is provided. The method comprising positioning 
cellular material on a support, identifying a region of interest 
of the cellular material, and generating an active array of 
illuminators that target unwantedregions of the cellularmate-
rial while allowing the region of interest of the cellular mate-
rial to be non-illuminated. 
According to a sixteenth aspect, a method of analyzing a 
biological sample is provided. The method comprising posi-
tioning cellular material on a first support, depositing a nega-
tive photosensitive material on the cellular material, applying 
a photomask comprising a blocking region onto the negative 
photosensitive material, exposing the negative photosensitive 
material to photons in order to generate a lithographic pattern 
on the negative photosensitive material, removing the photo-
mask, applying a developer to the negative photosensitive 
material in order to define one or more first access wells filling 
the one or more access wells with a reaction mixture com-
prising digestion agents and components necessary for a 
desired reaction, allowing the digestion agents to digest the 
cellular material thereby releasing the cellular contents into 
the reaction mixture, inactivating the digestion agents, filling 
one or more second access wells in a second support corre-
sponding to the one or more first access wells with an ana-
lytical reaction mixture, evaporating a fraction of the mixture 
to uniformly decrease the reaction mixture level, aligning the 
first support on top of the second support such that the one or 
more first access wells face the one or more second access 
wells securing the first and second support, inverting the 
secured support to allow the analytical reaction mixture to 
contact the cellular contents, and performing a reaction 
simultaneously but separately in each well of the array. 
According to a seventeenth aspect, a micro-isolation appa-
ratus is provided. The apparatus comprising a support, cellu-
lar material mounted upon the support, a photosensitive mate- 
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rial deposited on the cellular material, wherein the 
photosensitive material comprises an access well positioned 
to correspond to a region of interest of the cellular material, 
and a microfluidic device that provides access to the access 
well and is positioned adj acent to the photosensitive material. 
According to an eighteenth aspect, a method for selectively 
isolating cellular material is provided. The method compris-
ing positioning cellular material on a support, depositing a 
photosensitive material on the cellular material, applying a 
photomask comprising a blocking region onto the photosen-
sitive material, exposing the photosensitive material through 
a light accessible region of the photomask to photons in order 
to generate a lithographic pattern on the photosensitive mate-
rial, removing the photomask, applying a developer to the 
photosensitive material in order to define an access well cor-
responding to a region of interest of the cellular material, 
positioning a microfluidic device that provides access to the 
access well and is positioned adjacent to a photosensitive 
material located above the cellular material, and analyzing 
cellular material from the regions of interest. 
According to a nineteenth aspect, a method for selectively 
isolating cellular material is provided. The method compris-
ing positioning cellular material on a support, depositing a 
photosensitive material on the cellular material, exposing the 
photosensitive material to photons in order to generate a 
lithographic pattern on the photosensitive material, removing 
the photomask applying a developer to the photosensitive 
material in order to define an access well corresponding to a 
region of interest of the cellular material, positioning a 
microfluidic device that provides access to the access well 
and is positioned adjacent to a photosensitive material located 
above the cellular material, and analyzing cellular material 
from the region of interest. 
BRIEF DESCRIPTION OF THE DRAWINGS 
The accompanying drawings, which are incorporated into 
and constitute a part of this specification, illustrate one or 
more embodiments of the present disclosure and, together 
with the detailed description and the examples, serve to 
explain the principles and implementations of the disclosure. 
FIG. 1 shows a cross-sectional view of a series of steps in 
which tissue masking selectively destroys DNA. 
FIG. 2 shows a cross-sectional view of a series of steps 
where tissue isolation or masking is performed through lami-
nation with a photosensitive material. 
FIG. 3 shows a top view of an embodiment in which tissue 
isolation targets multiple areas of interest occurring by lami-
nation with a photosensitive material. 
FIG. 4 shows a cross sectional view where a tissue is 
integrated with microfluidic elements. 
FIG. 5A is related to FIG. 3, and illustrates a top view of a 
customized chambered microfluidic device. FIG. 5B is 
related to FIG. 3, and illustrates a top view of a standardized 
chambered microfluidic device. 
FIG. 6 shows a cross-sectional view of an embodiment 
where tissue encapsulation is performed. 
FIG. 7 illustrates an embodiment in which a maskless 
chambered microfluidic device encapsulates the tissue encap-
sulates a tissue without customized photomasking while 
specificity of micro-isolation is achieved through active con-
trol of arrays of valves allowing specificity of microisolation 
to be achieved through active control of arrays of valves. 
FIG. 8 illustrates a top view of a matrix of microfluidic 
wells. 
FIG. 9 shows a series of steps for the parallel processing of 
isolated tissue subsections. 
6 
FIG. 10 shows a series of steps for the parallel processing 
of isolated tissue subsections that allows step-wise adminis-
tration of biochemical agents. 
FIG. 11 illustrates an optical setup for dynamic optical 
5 array masking. 
FIG. 12 provides optical microscope optical microscope 
images as an Example of the techniques described herein. 
DETAILED DESCRIPTION 
to 
Methods and systems are provided herein that allow in 
several embodiments the integration of microfluidic tech-
niques with micro-isolation of light sensitive microscale 
15 components, such as cells and/or tissue. 
The term "microfluidic" refers to a system or device for 
handling, processing, ejecting and/or analyzing a fluid 
sample including at least one channel having microscale 
dimensions. Microfluidic tissue isolation can be customized 
20 morphologically, functionally, and a combination of the two. 
The term "micro-isolation" refers to the isolation of micro-
scale components (components having a size or measure in 
the order of micrometers) and in particular of light sensitive 
microscale components, which includes, but is not necessar- 
25 ily limited to, one or more biological components. A biologi-
cal component refers to any organized substance forming part 
of a living matter, e.g. a cell, cellular material, membranes, 
organelles, proteins, nucleic acids and/or living organisms of 
any dimensions or a part thereof (e.g. tissues or various cell 
30 extracts). Micro-isolation as used herein can refer to the iso-
lation of a single nucleus, a single cell or a biological com-
ponent thereof, a group of individual cells, or a cluster of 
cells, or a group of clusters of cells, or a specific region of a 
35 tissue or a portion thereof, or even cellular organelles (e.g. 
cell nuclei). In particular, in some embodiments, methods and 
system herein described allow one to simultaneously address 
a distributed group of regions of interest across a tissue slide 
while each region can be a single nucleus, a single cell, a 
40 cluster of cells or a biological component thereof. 
In some embodiments, the proposed integration of microf-
luidic techniques and micro-isolation of cellular material 
molds the microfluidic architectures in accordance with the 
particular structure of each specific biological component to 
45 be isolated. In particular, in some of those embodiments, the 
approach described herein is mainly built around the cellular 
material, following the tissue structure such that the devices 
and methods described herein are adapted to the specific 
geometry of particular tissues or other biological compo- 
50 nents. By contrast, in some of the traditional approaches 
microfluidic devices are structured taking only in accordance 
with engineering considerations (e.g. path minimization, flu-
idic efficiency), while the biological components in applied 
devices are forced to comply with these engineering presets 
55 and are not taken into consideration. 
In some embodiments, the subject matter described repre-
sents a paradigm shift in microfluidic technology because 1) 
microfluidic devices are directly integrated with, onto, or 
around tissue samples, in contrast to certain conventional 
60 method of off-chip sample extraction followed by sample 
insertion in microfluidic devices, 2) architectural and opera-
tional principles of microfluidic devices are mainly subordi-
nated to suit specific tissue structure and needs, in contrast to 
certain conventional method of building devices according to 
65 fluidic function alone and without regard to tissue structure, 
and/or 3) sample acquisition from tissue is to be performed 
on-chip and is to be integrated with the diagnostic measure- 
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ment within the same device, in contrast to the conventional 
method of off-chip sample prep and subsequent insertion into 
a diagnostic device. 
In an embodiment, a particular sample is hardwired using 
photolithographically defined masks. 
FIG.1 illustrates exemplary hardwired masks. Cells (110) 
inside a tissue slice (120) on a tissue support (e.g. glass slide) 
(130) are exposed to ultraviolet (UV) light (140) through a 
photomask (150) comprising blocking regions (e.g. chrome 
regions) (160) patterned on a transparent blocking support 
(e.g. glass slide) (170). The blocking regions (160) are pat-
terned in correspondence to cells of interest (180). The illu-
minating UV light (140) passes through a region of the trans-
parent blocking support that is not blocked (175) and is 
prevented from exposing an area (195) protected by the 
blocking region (160). DNA in exposed cells is destroyed 
(185) but protected DNA inside the cells of interest is pre-
served (190). 
The term "illumination" refers to the exposure of light. 
Light can be visible or non-visible light, and can be one or 
more of UV, two-photon, or multi-photon light or additional 
examples of light of various wavelength suitable to be used in 
connection with biological components which are identifi-
able by a skilled person upon reading of the present disclosure 
The term "hardwired" refers to devices, methods and sys-
tems herein described or portions thereof, that are tailored for 
a specific biological component of interest. For example, a 
particular device is hardwired if it is configured to be suitable 
for a specific component, e.g. a specific tissue to be investi-
gated using methods and systems herein described. In some 
embodiments, hardwired devices, methods and systems are 
herein described that are tailored not only for a specific bio-
logical component of interest, but also for a specific investi-
gative approach of interest. For example, in some embodi-
ments, hardwired masks are described that allow UV light to 
be directed only to areas of no interest so that the DNA, 
protein, or other biological material in those areas is damaged 
to various extents and even destroyed by photodamage. In 
some of those embodiments, damage in areas of interest not 
exposed to UV is minimized to various extents and in some 
cases even remain intact. The term "destroy" as used in the 
present disclosure with reference to an item indicates a dam-
age level able to impact at least one biological activity asso-
ciated to the item. The term "intact' as used in the present 
disclosure with reference to an item indicates a molecule that 
preserve all the biological activities associated to the item. 
In an embodiment, cells (or another biological components 
or microscale component) of interest can be identified, for 
example, using a microscopic computerized image of the 
slide and appropriate custom software, which can convert the 
selection into a digital image. The digital mask can be fed into 
• direct laser writer, e.g. Heidelberg DWL66, which transfers 
• digital mask onto the photosensitive material by direct writ-
ing with a resolution of 2 microns or higher (see Example 1). 
One skilled in the art would recognize that other laser writers 
or means for transferring digital masks with even higher 
resolution can be used with the claimed subject matter 
described herein. 
The term "micro-isolation apparatus" refers to a device that 
aids in the micro-isolation of a microscale component (e.g. a 
biological component, which relates to biology, life and/or 
living processes, such as a cellular material). 
The term "cellular material' refers to biological material 
pertaining to a biological cell. As used herein, it can refer to 
sub-components of a biological cell, a single intact biological 
cell, a group of biological cells, or a tissue. 
8 
The term "region of interest' as used herein pertains to a 
targeted area within cellular material. Definition of a targeted 
area can be of any dimensions and include one or more 
cellular material depending on the experimental design of 
5 choice. For example, the region of interest can be an area that 
is sought to be preserved, or an area that is sought to be 
damaged or even destroyed. In a further example, the region 
of interest can be as small as a DNA molecule, or as large as 
an entire tissue sample, a group of topologically non-contigu- 
io ous targeted areas in the tissue sample, which are all to be 
isolated and/or extracted at a same or a different time. 
The term "support" as used herein refers to any type of 
support in which cellular material can be mounted. One type 
of support is a glass slide, although one skilled in the art 
15 would recognize that many materials can provide support for 
cellular material. 
The term "photomask" as usedherein refers to the blocking 
support comprising a blocking region and a light accessible 
region. The term "blocking" refers to the ability of an item to 
20 hinder the passage of light through the item. The term "light 
accessible" as used herein refers to the ability of an item to 
allow passage of light through the item. In some embodi-
ments, the photomask can be any type of transparent support 
(light accessible region) having a non-transparent region 
25 (blocking region). In some embodiments, the transparent sup-
port can further be at least in part, semi-transparent, or trans-
lucent and/or include different blocking portions with differ-
ent blocking and light accessible capabilities (e.g. limited to 
one or more selected wavelengths for one or more areas of the 
so photomask). In some embodiments, the photomask can be a 
physical object (e.g. a glass slide partially covered with 
chrome, or a transparency partially covered with ink or other 
blocking material). In some embodiments, the photomask can 
be purely or partially digital. For example, in some embodi- 
35 ments, the photomask can comprise a series of instructions to 
a micro-mirror array, which operates so that some mirror 
elements are activated while others are not. In some of those 
embodiments, they activate mirror elements to form a photo-
mask pattern on a sample with respect to an illumination light 
4o reflected onto the sample by the micro-mirror array. Addi-
tional embodiments are encompassed by the present disclo-
sure wherein a photomask is dynamic photomask, as the 
instructions are dynamically defined in addition or in the 
alternative to photomask wherein physical blocking material 
45 (e.g. chrome coating) blocks light on a suitable support (e.g. 
glass slide). 
The term "blocking region" refers to a region of a blocking 
support that functions to block photons (e.g. non-transparent 
region blocking photons by absorption). In an embodiment, a 
5o blocked region can be a region of chrome covering the block-
ing support. One skilled in the art would appreciate that many 
metals or other materials could be used, for example, to block 
photon exposure. For example, titanium can be deposited on 
platinum, covered with a photosensitive material, and then 
55 similarly oxidized to produce a chemically and mechanically 
resistant oxide that can serve as a photon shield for agents 
damaging to micro-components such as cellular material, 
such as UV exposure. In some embodiments, a material form-
ing a blocking region can also further be a polarizer as will be 
60 understood by a skilled person. 
The term "blocking support" as used herein refers to a 
support that can be used to support a blocking region. For 
example, a blocking support can be transparent, or in general 
configured for allowing passage of a desired lighting in one or 
65 more areas where there is no blocking region. 
Embodiments of the present disclosure can use illumina-
tion light other than UV. For example, a two-photon or other 
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multi-photon approach would use illumination of larger 	 without damaging the biological materials of interest. In 
wavelengths where the resulting excitation would have an 	 those embodiments, photolithographic masking can thus be 
effective wavelength that is half or a smaller fraction of the 	 viewed as a way to use a photosensitive material as a microf- 
illumination light. Such illumination wavelengths provide 	 luidic element, which can be dynamically defined by optical 
increased resolution because the light intensity is a strong 5 methods and made to match the morphology and analytical 
function of the distance from the focal point, which allows 	 needs of the particular tissue sample. 
more precise focusing of the illumination laser. 	 FIG. 2 is an example of tissue isolation by lamination. (A) 
Hardwired masking can also be accomplished by other 	 A tissue (280) containing a cell of interest (205) is fixed on a 
methods, forexample, methods using polarizers and/orpolar- 	 tissue support (220). (B) A photosensitive material (210) is 
izer arrays. A polarizer surface can in principle be chemically io then deposited onto the tissue (280). The photosensitive mate- 
or optically modified to produce contrast between treated and 	 rial can be deposited on the tissue, e.g. by simple application, 
untreated regions to be used as a mask for the embodiments 	 by spinning the substance down on a spincoater, by kinetic 
described herein. Some polarizers can function on the prin- 	 mounting, or by using spacers (e.g. microspheres of fixed 
ciple of aligned molecular structure of polymers, while others 	 dimensions) and mechanical contact with a flat surface. (C) A 
are based on metal wire arrays. In either case, disrupting the 15 photomask (240) comprising a blocking region (245) is then 
structural order in chosen regions, for example by heating or 	 applied onto the photosensitive material (210). (D) The tissue 
melting, would make such regions lose their polarizer prop- 	 (280) is then exposed to UV light (230) through the photo- 
erty, which would produce the desired contrast between the 	 mask (240) and the photosensitive material (210). (E) Photo- 
regions of interest. Any hardwired method used produces a 	 exposure through the photomask (240) produces a litho- 
sample where the only remaining DNA and/or other biologi-  20 graphic pattern (250) inside the photosensitive material 
cal material of interest provides the sample of interest. Thus, 	 (210). (F) The photomask (240) is removed. (G) A developer 
the destroyed and/or other biological material of interest does 	 is applied (not shown) to remove non-cured sections of the 
not contribute noise to the signal. 	 photosensitive material, which leaves the areas of interest 
In an embodiment, cellular material can be micro-isolated 
	 (260) open to interaction with the outside world. (H). The cell 
by lamination of unwanted areas. 	 25 of interest (205) is unprotected and subjected to removal 
In an embodiment, micro-isolation by lamination provides 	 (270) for subsequent biochemical analysis (e.g. extraction or 
mutual isolation of non-contiguous regions of interest, while 	 in-situ measurements) whereas unwanted cells (215) are left 
preventing the material from contiguous or non-contiguous 	 inaccessible. 
unwanted regions from interfering with subsequent reactions. 	 Those skilled in the art would see that the described process 
In some of these embodiments, unwanted regions (e.g. DNA so utilizes "negative" photosensitive materials (photosensitive 
or proteins of interest) can be destroyed in subsequent pro- 	 material in which the protected areas are the areas that get 
cessing of the biological component of interest. In other 	 removed), but the same technique can be applied with "posi- 
embodiments, unwanted regions do not necessarily need to be 	 tive" materials as well, by inversion of the mask. 
damaged. In particular, in one embodiment DNA or other The term "developer" as used herein refers to a chemical 
regions of interest (damaged or not) can be locked inside the 35 that reacts with a chemical (e.g. a photosensitive material) 
laminate thus minimizing the possibility that contamination that has been exposed to light. 
of the region of interest can occur. In an embodiment, a 	 The term "lamination" or "to laminate" as used herein 
lamination approach further allows that each area of interest 	 refers to the placement or layering of a material, e.g. a pho- 
can be contacted with additional microfluidics for individual 	 tosensitive material, over a sample, including but not limited 
addressability and individual extraction. In an embodiment, 40 to, a tissue or cell sample, and the (thermal, photolitho- 
the nature of the photomasking (hardwired or dynamic) is 	 graphic, or otherwise) thickening or hardening of the lami- 
orthogonal to the choice of isolation method (e.g. DNA dam- 	 nating material into a "laminate," so that the biological com- 
aging or tissue lamination). In some of those embodiments, 	 ponents under the laminate are locked by it and cannot 
both photomasking methods are compatible with both isola- 	 contaminate the biological components in the non-laminated 
tion methods. 	 45 areas. 
In an embodiment, after identifying desired cells, a suitable 	 The term "photosensitive material" as used herein refers to 
lithography mask can be generated to protect the contents of 	 any organic soluble or water soluble material that experiences 
desired cells. In some of those embodiments, biological mate- 	 a change in solubility in a developer solution when exposed to 
rial such as DNA or protein from the protected cells can be 	 light, such as UV light. 
used in a number of downstream applications including, but 50 	 In an embodiment, one type of photosensitive material that 
not limited to, DNA sequencing, protein analysis, etc. The 	 can be used is photoresist. One skilled in the art would rec- 
purity of such specimens will greatly enhance the value and 	 ognize that many different types of photoresist materials can 
information of downstream applications. In some of these 	 be used such as negative (SUS) and positive (SPR and AZ) 
embodiments, the lamination method does not ensure 	 photoresists and additional photoresist identifiable by a 
destruction of unwanted biological material, but still maxi-  55 skilledperson. One skilled inthe art would further understand 
mizes survival of the wanted biological material, because the 	 that other photosensitive materials, or other photocurable 
latter is protected by the blocked regions of the photomask, 	 polymers, can be used with the embodiments described 
due to the requirements of the negative photoresist (see e.g. 	 herein. Any photo-curable material, which can include, but is 
FIG. 2). 	 not limited to, many types of polymer, elastomer, or epoxy, 
In an embodiment, the lamination-based method of micro- 60 can be used as a negative photosensitive material. Any sub- 
isolation relies on the fact that DNA and many other biologi- 	 stance that becomes soluble after UV exposure can act as a 
cal materials in tissue slice samples are neither damaged nor 	 positive photosensitive material, for example, urethane or 
removed by organic solvents (e.g. ethylene, acetone, xylene). 	 Polymethylmethacrilate (PMMA) and additional materials 
Thus, it is possible to produce a layer of photocurable mate- 	 identifiable by a skilled person. 
rial directly onto a tissue slice containing cellular material, 65 	 The use of a negative photosensitive material is shown in 
cure in situ by photoexposure with a desirable mask pattern, 	 FIG. 2. The "dark" areas of the mask are designed or pro- 
and then remove the uncured sections with organic solvents 	 grammed to allow access to the protected areas once the 
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developer is applied because negative photoresists use 
organic solvent developers, which neither damage nor extract 
DNA and RNA during the development process, because the 
DNA and RNA are charged and hydrophilic. Subsequently, 
the DNA and RNA can be extracted or analyzed in situ in 
aqueous solutions. 
The use of positive photosensitive materials causes the 
UV-exposed photosensitive material to be soluble in devel-
oper, such as an aqueous alkaline developer, so that areas not 
protected by the mask would be open to interaction (not 
shown). This allows hydrophobic molecules (e.g. hydropho-
bic lipid-soluble proteins) to be extracted by organic solvents 
that do not damage the positive photoresist coating of the 
unwanted areas. 
One skilled in the art would recognize that DNA and other 
biological material can be damaged by UV light. Nonethe-
less, one skilled in the art would also recognize that DNA 
most strongly absorbs light with a wavelength below about 
320 mu, while many photosensitive materials are activated at 
higher wavelengths, for example, at 400 mu. Although some 
light processing systems use a wide wavelength range, it can 
be appreciated that cut-off filters or other means that are 
commonly known can be used to limit the excitation light to 
wavelengths that are too long to damage DNA but are short 
enough to expose the photoresist, which can include, but is 
not limited to, wavelengths between about 350 mu and about 
400 nm as will be understood by a skilled person. 
Photoexposure can occur by any means known in the art, 
which includes, but is not limited to, UV exposure, light 
emitting diodes, or photonic crystal devices, or alternatively 
or in addition, reflected onto the sample by micro-mirror 
arrays. 
FIG. 3 shows from a top view the same process of tissue 
isolationby lamination as FIG. 2. (A) Clusters (310) ofpoten-
tial cancer cells within a tissue sample (320) are selected. The 
clusters provide a plurality of cells, each of which are targeted 
in a manner described in FIG. 2. (B) The selection is reflected 
in a photomask (either hardwired or dynamically defined) of 
black spots (330). (C) A photosensitive material (340) is 
deposited onto the tissue sample (320) and a tissue support 
(not shown); the photomask (330) is aligned on top, and UV 
light (not shown) is directed through the photomask (330) to 
expose the photosensitive material (340) over unprotected 
unwanted regions. (350) (D) The tissue slide (not shown) is 
treated (e.g. with a developer), which removes unexposed 
photosensitive material above the areas of interest. Defined 
access wells (370) in the photosensitive material (340) ensure 
that only the wanted areas can be extracted with suitable 
methods (e.g. chemically) for further analysis. 
The term "well' or "wells" or "access wells" or "defined 
access wells" as used herein describes an area around a tissue 
region of interest that provides access to that particular region 
of interest. 
In an embodiment, the tissue lamination approach is 
coupled with microfluidic devices placed on top of the pho-
to sensitive material in orderto individually analyzeregions of 
interest. 
A photolithographically masked tissue containing cellular 
material can be integrated with a microfluidic chip (e.g. con-
sisting of a series of chambers matching the mask) which can 
be fabricated in situ or separately. The chip can be used to 
extract the subsamples of the selected area. The chip can also 
be used to supply reagents for in-situ analysis (e.g. immu-
noassay, PCR, RT-PCR), which allows unequaled flexibility 
and parallelism in the microfluidic dynamic selection of tis-
sue areas of interest for each individual slide. 
As shown in FIG. 4, access wells (410) defined in a pho-
tosensitive material (440) over cells of interest (430) placed 
on a tissue support (450) can be accessed microfluidically by 
producing and aligning a chambered microfluidic device (e.g. 
5 a microfluidic chip) (420) comprising channels (470) having 
an input (480) and an output (490). 
As described herein, the term "microfluidic chip" or "chip" 
as used herein refers to at least one substrate having microf-
luidic structures contained therein or thereon. For example in 
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an embodiment, the chips can be one-layer, e.g. made of 
silicone, where horizontal channels are confined in a single 
2-D plane, with vertical channels only for input/output opera-
tions. The chips can also be multi-layer devices [ref. 2], where 
15 each layer of the material contains its own network of chan-
nels. Such networks can be connected with vertical connect-
ing channels called "vias" [ref. 3]. The chip can contain 
valves, or a plurality of valves and arrays of valves. One 
skilled in the art would appreciate that any chip that can be 
20 integrated with microfluidic wells defined in photosensitive 
material to allow for highly specific extraction of desired cells 
can be used. 
The term "channel' or "channels" or "chamber" or "cham-
bers" as used herein refers to a pathway formed in or through 
25 a medium that allows for the movement of fluids, such as 
liquids and gases. The term "input' or "inputs" as defined 
herein is intended to refer to areas of the microfluidic device 
where materials (e.g. proteolysis agents, gases, other liquids) 
can be introduced through the chambers to the regions of 
30 interest. The inputs further allow introduction of materials to 
multiple areas of interest through channels connected to the 
chambers. 
In various embodiments, a chip herein described can pro-
vide a multitude of analytical functions. The term "analyze" 
35 and "analytical' refer to activities related to process of the 
microscale component at issue for the purpose of detecting 
information related to the component. For example, in 
embodiments where the microscale component is formed by 
biological material, analytical functions comprise activities 
4o directed to process the biological material to identify infor-
mation concerning and/or originating from the material 
which are identifiable by a skilled person. For example, in an 
embodiment, the integrated chip can uptake micro-isolated 
cells, lyse such cells, capture DNA, RNA, and/or other bio- 
45 logical materials by specific or general hybridization assays 
to magnetic nanoparticles, which can then be extracted from 
the chip for traditional PCR analysis off-chip. In an embodi-
ment, the chip can also uptake the micro-isolated cells, lyse 
such cells, and perform PCR on-chip. In some of those 
50 embodiments, on-chip PCR allows subsequent detection of 
specific genes or mutations by molecular beacons or on-chip 
specific hybridization arrays. In an embodiment, the chip can 
also uptake a biological components such as micro-isolated 
cells, lyse such cells, and then perform immunoassays on 
55 intracellular proteins, e.g. for proteomics-level expression 
analysis. In an embodiment, the chip can also be used to 
extract the cell regions micro-isolated by the lamination tech-
niques described herein, separate the clusters into single cells, 
then feed each cell into a single-cell analysis device, e.g. for 
6o DNA sequencing, mutation detection, or gene expression 
analysis. Such devices as the enumerated examples can be 
used in fundamental research, and can also be adapted as 
biomedical diagnostic tools, e.g. in oncology and pathology. 
Additional variations of these devices, wherein same or fur- 
65 ther functionalities are added or combined are encompassed 
by the present disclosure as would be understood by a skilled 
person. 
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The term "output" or "outputs" as defined herein is 
intended to refer to areas where the cellular material from the 
regions of interest can be extracted for further analysis. Input/ 
output operations can be conducted by microfluidics, thus 
preventing contamination, waiting for diffusion, and exces-
sive dilution of the sample. Also, the chip itself can have 
analytical function, e.g. microfluidic immunoassays or 
microfluidic PCR and RT-PCR. 
In some embodiments, the described integration of tissue 
lamination micro-isolation with microfluidic devices allows 
the leveraging of the advantages of microfluidic handling 
(e.g. micro scale, fast diffusion, parallelism, integrated 
mechanical and/or chemical functionalities) with the advan-
tages of the described micro-isolation technique (e.g. high 
specificity, parallelism, low cost, flexibility, and/or dynamic 
masking). In some of those embodiments, this architecture 
provides flexible sample-specific interface between the 
unique patterns of the particular sample morphology and the 
hardwired architectures of conventional microfluidic devices. 
FIG. 5A shows a top view demonstrating a hardwired 
multi-chambered approach wherein regions of interest (from 
FIG. 3) are connected via channels. A laminated tissue 
sample (550) is integrated with a chambered microfluidic 
device (as shown in FIG. 4), whose channels (510) connect to 
chambers (as described in FIG. 4) over the laminated tissue's 
cellular areas of interest (540). An input (520) allows intro-
duction of components necessary to collect extracts into a 
single output (530). FIG. 5A shows a single input and output, 
although multiple inputs and outputs are possible. In this 
particular approach, the entire chip is customized to the 
extraction needs of the particular sample, although as 
described herein, multiple approaches are possible. 
In an embodiment, the lamination is customized to the 
particular sample, but the rest of the microfluidic device can 
be standardized and thus used universally with any and all 
tissue samples. As used herein, a universal microfluidic 
device is a device that can be standardized and used with 
multiple tissue samples that have been selectively or non-
selectively isolated. For example FIG. 5B shows a top view 
demonstrating a standardized multi-chambered approach. In 
this approach, a laminated tissue (550) is integrated with a 
chambered microfluidic device (as shown in FIG. 4), whose 
standardized matrix of channels (560) connect to chambers 
(as described in FIG. 4) over the laminated tissue's cellular 
areas of interest (540). An input (520) allows introduction of 
components necessary to collect extracts into a single output 
(530). FIG. 5B shows a single input and output, although 
multiple inputs and outputs are possible. Those skilled in the 
art would appreciated that a standardized multi-chambered 
chip can be configured in one of many possible ways in order 
to allow microfluidic channels to cover a tissue surface 
adequately in order to extract desired cells from randomly 
distributed locations. For example, the grid canbe rectangular 
as shown in FIG. 513, or a binary tree of parallel channels. In 
addition, a universal extractor device can be combined with a 
sample-specific micro-isolation technique. In embodiments, 
wherein the spacing in a grid or mesh of channels is not bigger 
than the expected size of wanted clusters, a fluidic connection 
between one or more wanted cluster with at least one of the 
extraction channels can be performed. Thus in some of those 
embodiments a universal extractor device can be combined 
with a sample-specific micro-isolation technique (e.g. the 
described lamination method). In some embodiments, in par-
ticular the described combination can have the benefits of 
both techniques in the same system low cost and universal 
14 
applicability offered by the standardized chip with the high 
specificity and sample-specific customization of the micro-
isolation technique. 
In an embodiment, a tissue is completely encapsulated 
5 inside a microfluidic device, to allow for full surface access. 
Tissue encapsulation captures a tissue of interest between 
two separate microfluidic devices, which allow simultaneous 
access to two surfaces. If the slice is sufficiently thin, fluidic 
communication is ensured through the slice. Such communi- 
io cation allows more efficient and reliable extraction of desired 
samples, as a resuspension liquid can be used to push desired 
material out of the tissue matrix. This approach allows extrac-
tion of desired material by microfluidic/hydraulic means 
without the need for more aggressive chemical treatments. 
15 FIG. 6 illustrates an embodiment where complete encap-
sulation is shown. A tissue slice (630) covered in a photosen-
sitive material both above (620) and below (625) the tissue 
slice and defined by access wells both above (660) and below 
(665) the tissue slice that can be integrated with microfluidic 
20 devices (e.g. microfluidic chips) positioned above (610) and 
below (615) the cells of interest and having chambers from 
both above (670) and below (680) the tissue slice. This archi-
tecture allows a more efficient input (640) and output (650), 
while an area of contact (690) canbe doubled forbetter access 
25 to the cells of interest (695). 
In an embodiment, tissue encapsulation allows the use of 
3D polymerization for in-situ chip construction around the 
3D tissue sample. This can be done, e.g. by using direct laser 
writing and 3D rastering to build the desired architectures 
so such that the monomer material for the chip can be spread 
thick over the tissue sample. The laser can then polymerize 
the chip material in the desired shape over the tissue sample. 
The tissue is completely submerged in a monomer, while a 3D 
chip is built around it, thus allowing microfluidic access to the 
35 sample from all directions. In some embodiments, performed 
according to this approach, the photocurable polymer of the 
chip material itself can be used as a photosensitive material, 
wherein a tissue slice can be placed inside the polymer prior 
to 3-D photopatterning (e.g. before a 3-D photopatterning 
40 commences). 
In an embodiment, multiple areas of interest are addressed 
with individual channels without masking. 
Individually and collectively controlled arrays of microv-
alves, which allow the same architecture to address a customi- 
45 zable subset of chambers of access loci within the matrix, can 
provide the ability to match particular regions of interest on 
the particular tissue sample. A chip with a dense pore matrix 
allows the differential opening of particular pores for a short 
time such that only material confluent with the pore would 
50 flow from the sample into the chip for analysis without mask-
ing. 
Maskless microfluidic encapsulation is shown in FIG. 7. A 
tissue slice (710) is encapsulated in a dense pore matrix 
microfluidic device both above (745) and below (750) the 
55 tissue. Individually addressable valves that are closed are 
shown marked with an "X" (770) as opposed to valves that are 
open (760) to allow flow through the open channel (755). The 
open valve (760) forces a pressure drop that ensures input 
flow (720) and forces material from a cell (740) through a 
60 pore (73 0) into an output channel (780) and through an output 
(790) for analysis. 
An embodiment provides tissue micro-isolation by microf-
luidic matrices for parallel analysis of subsamples with pre-
served morphological context. 
65 	 According to an embodiment, microfluidic matrices with 
highly parallel single-cell analysis is based on the combina- 
tion of a nanofabricated microfluidic matrix and a tissue 
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section. This allows a matrix of millions of microfluidic wells 	 (1050) having blocking regions (1055) is placed over the 
to be filled with biochemical reagents and contacted to a 	 photosensitive material and exposed to UV light (1040) 
tissue section deposited on a support. For example, each well 
	 (Panel B). Next, the photomask is removed and an organic 
can contain Proteinase K and sequencing reagents. The Pro- 	 solvent developer removes the photosensitive material from 
teinase K digests the tissue and releases the contents of each 5 the unprotected areas, leaving defined access wells (1060) 
cell into its adjoining well, where they mix with the PCR 	 (Panel Q. The defined access wells are filled with solution 
reagents by diffusion. The entire system is contacted to a 	 containing Proteinase K (1065) (Panel D), which digests 
thermally controlled aluminum plate, to perform standard or 	 exposed tissue (1070) and releases the DNA into the solution 
isothermal PCR. Mutant genes can be amplified by appropri- 	 in each well (Panel E). Heating deactivates the Proteinase K 
ate selection of primers and reported by fluorescent probes. io  and lyophilizes DNA in place in each respective well (1075) 
Signal detection is done by scanning the entire slide on a 	 (Panel F). Next, a corresponding matrix of wells is etched in 
fluorescence scanner or by fluorescence microscopy per- 	 a well support (e.g. silicon, glass, or silicon-on-insulator) 
formed one sector at a time followed by digital assembly. The 	 (1080), which is filled a solution containing PCR reagents 
result is a highly parallelized single-cell (genetic) analysis of 	 (1085) (Panel G). The assembly is then mechanically secured 
the entire tissue. 	 15 together (e.g. clamped) providing water-tightness between 
An exemplary matrix of microfluidic wells according to an 	 compartments, and then turned over, allowing the PCR solu- 
embodiment herein described is illustrated in FIG. 8, which 	 tion to resuspend the lyophilate within each well (1090) 
shows a top view of access wells (810) inside a matrix (820) 	 (Panel H). PCB can proceed simultaneously yet separately, in 
(built in e.g. glass silicon, or silicon-on-insulator). Access 	 which fluorescent probes (1095) reveal results of the reaction 
wells (810) can be defined, for example, by spreading a pho-  20 (see starbursts Panel I). Data acquisition can be performed 
toreactive material on a substrate, exposing the photoreactive 	 e.g. on a fluorescence scanner or by an optical fluorescence 
material to UV light through a photomask, developing the 	 microscope, where the wells are optically accessed by the 
photoreactive material, and etching the exposed areas. Fol- 	 side of the glass slide in panel I. 
lowing removal of the photoreactive material, the result is 	 In the embodiment exemplified in FIG. 10, when the sur- 
defined access wells in the substrate with the same geometry 25 face density and size of the wells are correctly chosen, most 
as the photomask. The term "dense-pore matrix" as used 	 wells will adjoin one and only one cell. In some embodi- 
herein refers to a matrix having dense pores. 	 ments, wherein the biological component is formed by cells, 
FIG. 9 shows an exemplary illustration of how a matrix of 	 an expected optimal well size is about the same as the size of 
microfluidic wells can provide access to individual cell nuclei 	 a mammalian cell (-20 µm). However, in those embodiments, 
for independent reactions. Microfluidic access wells (910) 30 one skilled in the art would recognize that the size and spacing 
are defined in a substrate (920) (e.g. glass or silicon). Next, 	 of the wells can be optimized to ensure that the overwhelming 
the access wells (910) are filled with a fluid mixture (930) 	 majority of wells contain just one cell. This would maximize 
containing digestion and reaction agents (e.g. Polymerase 	 purity of the sample in each well, and thus maximize speci- 
Chain Reaction (PCR) reagents, and fluorescent probes). 	 ficity and reduce noise in an analytical determination. 
Next, evaporation is performed to uniformly decrease the 35 	 In an embodiment, a maskless microisolation apparatus 
fluid mixture level (940), leaving space at the top (945) of the 	 methods and systems are described that are configured 
microfluidic access wells. Next, a tissue support (950) is 	 according to the micro scale component of interest and experi- 
aligned on top with a tissue slice (960) facing downward. 	 mental design and do not require (although they could 
Next, an assembled construct (955) is clamped together and 	 include) photomasks and/or photosensitive material. For 
vertically turned over, allowing the fluid mixture to flow by 40 example, in some of those embodiments, a maskless 
gravity and cover (975) the tissue. Next, the digestion agents 	 microisolation apparatus can have randomly placed access 
contained in the fluid mixture break down the tissue (965), 	 wells that are configured relative to the biological material of 
releasing the cellular contents into the microfluidic access 	 interest and the experimental design. In particular, in embodi- 
wells (910). The reaction reagents within the fluid mixture 	 ments where the biological material is comprises cells and the 
complete the reactions and fluorescent probes (980) reveal 45 experimental design is directed to isolate and/or analyze indi- 
results. 	 vidual cells, a dense porous "honeycomb" arrangement of 
In an embodiment, releasing the cellular content of the 	 predetermined access wells can be used in a device, methods 
tissue can be performed by digestion of the tissue performed 	 or systems herein described such that the pre-existing access 
using Proteinase K. or other techniques of chemical digestion 	 wells can be placed accordingly over cellular regions accord- 
such as the ones described in [ref. 4,5] which allow multiple 50 ing to the specific analysis of choice (e.g. to perform protein 
analysis of different molecules in the cellular component. For 	 and/or DNA analysis of regions of interest selected). 
example, in an embodiment techniques can be used that allow 	 In some embodiments, the configuration of a matrix of 
immunoassay analysis of the extracts as well as DNA and 	 access wells herein described is not limited to desirable areas 
protein analysis at various scales as it will be understandable 	 alone. In some of those embodiments, some or all wells can be 
by a skilled person. 	 55 analyzed simultaneously but separately, so that no predeter- 
In several embodiments, the nanomatrix technique herein 	 mined regions are necessary. Accordingly, in an embodiment, 
described can be modified in view of the specific reagents, 	 of devices methods and systems herein described a photo- 
biological component, desired result and experimental design 	 mask can be designed to single out only the areas of interest 
as will be understood by a skilled person. For example, in an 	 and/or to include a repeating regular or irregular geometric 
embodiment, a matrix of microfluidic wells can provide 60 pattern of choice (e.g. circles, squares, or hexagons in rect- 
access to individual cell nuclei where a two-step process 	 angular, checkered, or honeycomb formation) of appropri- 
allows separate biochemical reactions to occur. By way of 	 ately chosen size and spacing, e.g. to contain only one micros- 
example, FIG. 10 shows a process in which cells can be 	 cale component or portion thereof (e.g. one cell per well). 
digested with Proteinase K prior to a PCR reaction. In the 	 In several embodiments, wells of a masked or maskless 
illustration of FIG. 10 tissue (1030) is placed atop of  support 65 matrix of access can include one or more reaction mixtures. A 
(1010) and a photosensitive material (e.g. negative photore- 	 reaction mixture can be any mixture containing components 
sist) (1020) covers the tissue (Panel A). Next, a photomask 	 necessary for a biochemical reaction to occur. Reaction mix- 
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tures can include, but are not limited to, components neces- 	 In an embodiment, the digital image can also be 3-D, e.g. in 
sary for PCR, real-time PCR, RT-PCR, flow cytometry, fluo- 	 embodiments, when a device is provided for tissue encapsu- 
rescent labeling, FRET, DNA sequencing, protein-protein 	 lation by 3-D rastering of the photocuring illumination, as 
interaction assays, immunoassays, protein-nucleic acid 
	
described herein. A "digital mash' refers to the masking of a 
assays, and any other biological reaction known in the art. 	 5 region of interest of cellular material based on a digital image 
A matrix of microfluidic wells allows incomparable paral- 	 as opposed to a physical mask, e.g. a chrome mask. 
lelism in extracting the sequencing information while pre- 	 In an embodiment, tissues can be micro-isolated without 
serving the morphological and contextual information from 	 the need for a physical mask for UV shielding. Instead, a UV 
the tissue sample. It enables large-scale mapping of two- 	 laser, e.g. Heidelberg DWL668, can be focused directly onto 
dimensional spatial distribution of mutations across a tumor io the necessary spots in the photoresist on top of the tissue for 
section. If such maps are made of consecutive sections of the 	 lamination or in the tissue itself for destruction of biological 
same tumor, a three-dimensional distribution of mutations 	 material in the tissue such as DNA. The resolution can be 2 
within a tumor can be digitally assembled. Furthermore, such 	 microns or better, and the desired cells can be skipped in the 
3D maps can be generated for analogous tumors in multiple 	 rastering process. Different laser heads can be used for the 
test animals at different temporal points of tumor evolution. 15 different regions of the slide. For example, appropriate soft- 
Thus, the temporal evolution of a 3D distribution of mutations 	 ware can guide the laser with a 2-micron head around the 
can be assembled. 	 immediate vicinity of the cells of interest, while the rest of the 
In many embodiments, the optimal well size is the same 	 slide area is exposed by broader strokes, e.g. with a 30-micron 
size as a mammalian cell (approximately 20 µm), although 	 head. 
one skilled in the art will recognize that different well sizes 20 	 In an embodiment, active masking arrays utilize LCDs 
can be used for different applications. 	 (liquid crystal displays). An illumination light would be 
In an embodiment, an active array of masking material 	 polarized along one axis, while the LCD elements would be 
replaces a physical mask with micro-mirror arrays. As illus- 	 polarized along one axis to disallow and another axis to allow 
trated in FIG. 11, which is a dynamic process allows the 	 the passage of the UV light. The cells of interest are protected 
targeted positioning of tissue selection. First, cells and/or 25 by having the corresponding elements in the array be perpen- 
tissue (1160) are shown to an operator and a camera (1110) 	 dicularly aligned, while the unwanted cells would have their 
takes an image of cells and/or tissue through an adjustable 	 elements aligned in parallel with incident UV illumination. 
mirror (1120), a Digital Light Processing (DLP) mirror 	 In an embodiment, dynamic masking using fiber optics can 
(1130) and a photosensitive material (1140). The image 	 be produced by arrays of LEDs (light emitting diodes). This 
shows the cells and/ortissue (1160) placed on a tissue support 3o approach allows the utilization of increasing smaller wave- 
(1150). Upon observation of the image, an area of interest is 	 lengths as current technology builds LEDs at smaller wave- 
selected by programmable patterning the DLP mirror (1130). 	 lengths. Individually addressable elements can be built at the 
Second, the adjustable mirror (1120) is adapted to be posi- 	 microscale, producing macro-sized arrays of thousands or 
tioned accordingly so that UV light from a lamp (1170) can be 	 millions of individually addressable LED elements. Such 
directed through a long-pass filter (1180) and through the 35 individually addressable LED elements allow respective 
programmed DLP mirror (1130) onto the photosensitive 	 areas on the photosensitive material to be individually pho- 
material (1140) and directed to destroy the DNA of the cells 	 topolymerized to provide the tissue lamination methods 
in the region of interest (1160). 	 described herein. 
A long-pass filter indicates a device that operates to allow 	 In an embodiment, fiber optics is used in a way similar to 
all light coming from the UV light having a wavelength above 40 intensified CCD cameras. Bundles of fiber optic cables are 
a certain value, e.g. about 350 mu. Long-pass filters are stan- 	 arranged to produce an active array of illuminators. This 
dard optical elements known to people skilled in the art. The 	 bundle can be coupled to an LCD array at the input of illu- 
particular long-pass filter suitable for the embodiment exem- 	 mination light, while the output is coupled to the tissue slide. 
plified in FIG. 11 is configured to ensure that virtually all light 	 Then the output size of each fiber can be made smaller than 
coming from the illumination source has a wavelength above 45 the input size, producing both light transduction and size 
the cut-off value of about 350 mu. The usual structure of long 	 reduction. 
pass filters is a Bragg stack of layers of dielectric materials 	 In an embodiment, active masking array uses photonic 
with carefully controlled thicknesses. The thickness and 	 circuitry to define dynamic optical arrays. A photonic circuit 
refractive index of each layer sets up destructive interference 	 can in principle be built to generate an array of individually 
for a narrow band of wavelengths that are meant to be 5o addressable optical outputs. When positioned over a tissue 
stopped. Making a stack of such layers ensures that a wider 	 slide, the individual addressability of optical outputs provides 
cumulative range of wavelengths is stopped by the filter. In 	 the capability for individual UV exposure of tissue areas that 
this particular case, the cut-off value is 350 mu, because 	 are chosen to be discarded. 
wavelengths above it are too long to damage DNA when DNA 
	
In an embodiment, active masking array uses photonic 
is chosen as microscale component of interest, but short 55 circuitry to define dynamic optical arrays. A photonic circuit 
enough to expose the photoresist correctly. In the exemplary 	 can in principle be built to generate an array of individually 
system of FIG. 11 the long pass filter is for the tissue lami- 	 addressable optical outputs. When positioned over a tissue 
nation method, which necessitates the exposure of the pho- 	 slide, the individual addressability of optical outputs provides 
toresist which becomes the laminate. People skilled in the art 	 the capability for individual UV exposure of tissue areas that 
(e.g. optics and engineering) understand all the possible 6o are chosen to be discarded. 
variations of long-pass filters in devices, methods and filters 	 In an embodiment, active masking array uses micro- and 
herein described. 	 nano-lasers for dynamic arrays. These lasers can be fabri- 
The term "digital image" refers to an image generated by a 	 cated in arrays, where each laser is still individually addres- 
computer or other suitable electronic device. In an embodi- 	 sable. Software and electrical outputs control which laser is 
ment, a digital image can be provided, for example, by a set of 65 active, e.g. by electrical pumping or electrical control of 
instructions in software on a computer controlling the optical 	 polarization shielding against pumping illumination. Microf- 
hardware. In an embodiment, the image can be a 2-D image. 	 luidic devices can further follow a combination of morpho- 
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logical and functional customization. For example, in the 
particular technique of multi-layer elastomer microfluidics, 
the elastomeric layer that contacts the sample can have a 
photolithographically defined morphology that matches the 
regions of interest in the tissue sample, while other layers can 
follow a matrix or array structure built for functional pro-
grammability As an example, see FIG. 5A, where a uniform 
matrix of channels overlays the wells of the regions of inter-
est, ensuring extraction. Thus the extraction matrix can be 
standardized and thus produced inexpensively, while the 
laminating layer is kept specific to the particular tissue 
sample. One skilled in the art would appreciate that such a 
combination is clearly not limited to extraction alone, 
because a device of any processing or analytical function can 
be integrated with a sample-specific micro-isolation stage. In 
some embodiments, the specific functionality or purpose of 
the device can be combined with the high specificity and 
sample-specific customization offered by the described 
micro-isolation techniques. In some of those embodiments, 
this approach provides a low cost of standardization with a 
high specificity of sample-specific extraction 
In some embodiments, the methods and devices described 
herein overcome various problems e.g. by providing a general 
microfluidic bottoms-up sample-specific customization 
method. Such a method naturally leads to rapid, parallelized, 
and highly specific micro-isolation of the desired cell sub-
population (e.g. cancer cells from a tumor) directly from 
tissue samples. In particular, in some embodiments, devices, 
methods and systems herein described preserve the structural 
integrity of most of the tissue, thus preserving its inherent 
morphological information. In some embodiments, a PCR 
nanomatrix technique is described that allows parallelized 
large-scale high-throughput genomic mappings across the 
tissue sample. 
In several embodiments, methods herein described allow 
convenient application in a number of methods to separate 
normal from cancer cells (See Ref. 1). Methods herein 
described are not necessarily dependent on use of fresh tis-
sues, and are applicable to most human cancer specimens, 
which are usually fixed in formalin and paraffin-embedded. 
In some embodiments, devices methods and systems herein 
described allow to process wanted cells (e.g. cancer cells) 
minimizing the background noise of unwanted cells (e.g. non 
cancerous cells). In some of those embodiments, devices, 
methods and systems herein described allow a less expensive 
and less labor-intensive of certain methods of the art where a 
trained operator must manually identify and then individually 
address each cell to be analyzed using an expensive and 
complex laser microscopy system. 
In some embodiments, devices, methods and systems 
herein described can be performed in microfluidics. In par-
ticular, in certain embodiments, microfluidics is the micro-
manipulation of fluids, and can be integrated with biochemi-
cal applications for microscale analyses of cells with further 
implementation identifiable by a skilled person. 
In several embodiments, devices methods and systems 
herein described are configured to combine sample specific 
microisolation with standardized processing and/or analysis 
chip. Microisolation can be used to control and in particular 
increases up to maximize specificity of selection. Use of a 
standardized processing and/or analysis chip can provide an 
economic and industry friendly way to materialize the tech-
nique in practice. 
According to several embodiments, microisolation devices 
methods and systems are described wherein: cellular material 
or other microscale component is positioned on a substrate; a 
sample specific micro isolation method herein described is 
applied to the cellular material or other component to obtain 
a substrate presenting the cellular material, a microfluidic 
universal device is connected with or contacted to the sub-
strate presenting the cellular material, the universal device 
5 being analysis specific and sample non specific; and a 
microisolation methods is used to extract the material from 
the desired regions on the particular sample and the universal 
device is used to collect and/or analyze the extracted sample 
Although any methods and materials similar or equivalent 
10 to those described herein can be used in the practice for 
testing of the products, methods and system of the present 
disclosure, exemplary appropriate materials and methods are 
described herein as examples. 
15 	 EXAMPLES 
The devices, methods and systems herein described are 
further illustrated in the following examples, which are pro-
vided by way of illustration and are not intended to be limit- 
20 ing. 
In particular, the following examples illustrate exemplary 
hardwired and laminated devices and related methods and 
systems. A person skilled in the art will appreciate the appli-
cability and the necessary modifications to adapt the features 
25 described in detail in the present section, to additional solu-
tions, devices, arrangements, methods and systems according 
to embodiments of the present disclosure. 
Example 1 
30 
Hardwired Masking Using Photolithographically 
Defined Chrome Masks 
Cells of interest are identified using a microscopic com- 
35 puterized image of the tissue slide and appropriate custom 
software, which converts the selection into a digital image. 
The digital mask is fed into a direct laser writer, the Heidel-
berg DWL66®, whichtransfers a digital mask onto the "posi-
tive" photosensitive material deposited on top of a chrome- 
40 covered plate, by direct writing with a resolution of 2 
microns. The plate is then developed to remove the exposed 
photoresist, which leaves the exposed areas susceptible to 
chemical etching. The etching removes the unprotected 
chrome, and the rest of the photosensitive material is 
45 removed, e.g. by overdevelopment or exposure to a strongly 
alkaline solution. The remaining chrome pattern is quickly 
oxidized by atmospheric exposure, typically within 30 sec, 
which produces a chrome mask specific to the particular 
tissue sample. An exemplary hardwired masking using pho- 
50 tolithographically defined chrome masks is illustrated in FIG. 
1. 
Example 2 
55 	 Application of Tissue Lamination Approach to 
Adrenal Gland Tissue Slides 
The tissue lamination technique was applied to adrenal 
gland tissue slides preparedby routine clinical methods. Pho- 
60 toresist SUS-2005 was deposited onto a tissue by spinningthe 
slide on a WS-40013-6NNP/LITE spincoater. The slide was 
pre-baked at 65'C. Next, the slide was exposed to UV filtered 
with a 368-nm high-pass filter at an MA-6 mask aligner, 
through a chrome-on-glass mask bearing the pattern of a 
65 USAF 1951 resolution chart. The chart was chosen as a mask 
to provide an easily identifiable reference in terms of size of 
the defined features in photoresist on top of the tissue. 
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The slide was then post-exposure baked at 95° C. and 
developed in SUS developer, which contains organic sol-
vents. Finally, each slide was characterized on a profilometer 
(Alpha-Step 500) to measure the height of the fabricated 
features. Tissue slice thickness was measured up to 5 µm 
tissue, while the photoresist layer was —7 µm high. FIG. 12 
shows the "windows" defined in the photoresist. The dimen-
sion defined on the tissue was —12 µm width, which is smaller 
than a typical mammalian cell (20 µm). 
The tissue section is essentially unchanged after photoli-
thography (see FIG. 12A), except for the discoloration of 
unmasked areas due to the leeching of the hematoxylin and 
eosin staining by the organic solvent of the photoresist devel-
oper. Some of this discoloration extends under the mask (see 
FIG. 12A, 12D), likely because the organic solvent is a very 
small molecule that can penetrate through the tissue to reach 
the masked areas. An alternative explanation is that the dye 
can diffuse out into the wells during the digestion and extrac-
tion process, leaving the areas of immediate proximity to the 
wells. It is noted however that the nuclei remain in the 
unwanted areas but are extracted from the wanted areas 
therefore, the unwanted DNA cannot diffuse out the way the 
dye can. 
The laminated areas of the tissue appear far brighter than 
the exposed tissue (see FIG. 12A) because the refractive 
index of the photoresist matches the refractive index of the 
tissue better than air, while the photoresist also mechanically 
smoothens the surface roughness of the tissue. Thus surface 
light scattering and refractive divergence are significantly 
reduced, and the intensity of the detected light is increased 
over the laminated areas, in comparison to non-laminated 
tissue. 
To extract the exposed tissue, a drop of extractions solution 
(10 mM Tris-HCl, 2 mM EDTA, pH 8.0, with 10 mg/ml 
Proteinase K) is placed on top of the masked slide and incu-
bated at 56° C. in a humidity chamber. The Proteinase K 
digests the tissue, releasing the DNA into solution, which is 
then suitable for amplification by PCR. The slide after diges-
tion (FIGS. 12B, 12C, 12D) shows the removal, with sharp 
boundaries defined by the mask, because Proteinase K is a 
large protein and thus unable to diffuse through the tissue. As 
seen in FIG. 12B, the digestion is less efficient with smaller 
features, because the photoresist is hydrophobic and so sur-
face tension works as counterpressure against the entry of the 
extraction solution into the smaller holes. 
The embodiments and examples set forth above are pro-
vided to give those of ordinary skill in the art a complete 
disclosure and description of how to make and use the 
embodiments of the devices, systems and methods of the 
disclosure, and are not intended to limit the scope of what the 
inventors regard as their disclosure. 
The examples set forth above are provided to give those of 
ordinary skill in the art a complete disclosure and description 
of how to make and use the embodiments of the arrange-
ments, devices, compositions, systems and methods of the 
disclosure, and are not intended to limit the scope of what the 
inventors regard as their disclosure. All patents and publica-
tions mentioned in the specification are indicative of the lev-
els of skill of those skilled in the art to which the disclosure 
pertains. 
The entire disclosure of each document cited (including 
patents, patent applications, journal articles, abstracts, labo-
ratory manuals, books, or other disclosures) in the Back-
ground, Summary, Detailed Description, and Examples is 
hereby incorporated herein by reference. All references cited 65 
in this disclosure are incorporated by reference to the same 
extent as if each reference had been incorporated by reference  
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and there is no intention in the use of such terms and expres-
sions of excluding any equivalents of the features shown and 
described or portions thereof, but it is recognized that various 
modifications are possible within the scope of the disclosure 
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this disclosure as defined by the appended claims. 
It is also to be understood that the terminology used herein 
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Whenever a range is given in the specification, for example, a 
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are intended to be included in the disclosure. Any one or more 
individual members of a range or group disclosed herein can 
45 be excluded from a claim of this disclosure. The disclosure 
illustratively described herein suitably can be practiced in the 
absence of any element or elements, limitation or limitations 
which is not specifically disclosed herein. 
A number of embodiments of the disclosure have been 
50 described. The specific embodiments provided herein are 
examples of useful embodiments of the disclosure and it will 
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device components, methods steps set forth in the present 
55 description. As will be obvious to one of skill in the art, 
methods and devices useful for the present methods can 
include a large number of optional composition and process-
ing elements and steps. 
In particular, it will be understood that various modifica- 
60 tions may be made without departing from the spirit and 
scope of the present disclosure. Accordingly, other embodi-
ments are within the scope of the following claims. 
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What is claimed is: 
1. A method to analyze a biological sample, the method 
comprising 
positioning cellular material on top of a first support, 
applying a microisolation apparatus comprising a plurality 
of first access wells on top of the cellular material, said 
cellular material defining bottoms for the first access 
wells; 
filling the plurality of first access wells of the microisola-
tion apparatus on top of the cellular material with a 
mixture comprising digestion agents and components 
necessary for a desired reaction; 
allowing the digestion agents to digest the cellular material 
thereby releasing cellular contents into the mixture in 
each well of the plurality of first access wells; 
inactivating the digestion agents; 
fixing the cellular contents in their respective wells; 
filling aplurality of second closed bottom access wells of a 
second support corresponding to the plurality of first 
access wells with an analytical reaction mixture; 
evaporating a fraction of the mixture to uniformly decrease 
the reaction mixture level across the plurality of second 
closed bottom access wells leaving a space at the top of 
the plurality of second closed bottom access wells; 
aligning the first support on top of the second support such 
that the plurality of first access wells face the plurality of 
second closed bottom access wells, 
24 
securing the first and second support to form a secured 
support; and 
inverting the secured support to allow the analytical reac-
tion mixture to flow from the second closed bottom 
5 access wells into the first access wells and via gravity 
contact the cellular contents in order to perform a reac-
tion simultaneously but separately in each well of the 
secured support. 
2. The method of claim 1, wherein the analytical reaction 
10 comprises one or more reagents for PCR, real-time PCR, 
RT-PCR, flow cytometry, fluorescent labeling, FRET, DNA 
sequencing, protein-protein interaction assays, immunoas-
says, protein-nucleic acid assays. 
3. The method of claim 1, wherein signal detection is 
15 accomplished by scanning a completed reaction using a fluo-
rescence scanner and/or a fluorescence microscope. 
4. The method of claim 1, wherein the filling the plurality 
of second closed bottom access wells of the second support 
corresponding to the plurality of first access wells with the 
20 analytical reaction mixture occurs after the digestion agents 
have digested the cellular material. 
5. The method of claim 1, wherein the filling the plurality 
of second closed bottom access wells of the second support 
corresponding to the plurality of first access wells with the 
25 analytical reaction mixture occurs before filling the plurality 
of first access wells with the mixture comprising digestion 
agents. 
6. The method of claim 5, wherein the analytical reaction 
mixture is dried. 
30 	 7. The method of claim 6, wherein the dried analytical 
reaction mixture is resuspended by the reaction mixture com-
prising digestion agents. 
8. The method of claim 1, wherein the reaction and the 
digestion of cellular materials occur simultaneously but sepa-
35 rately. 
9. The method of claim 1, wherein applying a microisola-
tion apparatus comprises: 
depositing a negative photosensitive material on the cellu-
lar material; 
40 	 applying a photomask comprising a blocking region onto 
the negative photosensitive material; 
exposing the negative photosensitive material to photons in 
order to generate a lithographic pattern on the negative 
photosensitive material; 
45 removing the photomask; and 
applying a developer to the negative photosensitive mate-
rial in order to define the plurality of first access wells. 
